Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery
- PMID: 10758306
- DOI: 10.1016/s0360-3016(00)00415-6
Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery
Abstract
Purpose: The use of radical radiotherapy and surgery for salvage (RRSS) in locally advanced squamous cell carcinoma (SCC) of the larynx is controversial. In the absence of randomized studies, it is unclear if RRSS can match the rates of locoregional control and survival reported for primary surgery in this setting. The aim of this study was to compare treatment outcomes of radiotherapy and surgery in comparable patients with CS III-IV SCC of the larynx.
Methods and materials: Eighty-two patients with untreated T2N+M0 or T3T4NM0 SCC of the larynx were treated with a policy RRSS at the Toronto-Sunnybrook Regional Cancer Centre between June 1980 and December 1990. The medical records at presentation were reviewed independently by a panel of three surgical oncologists blinded as to treatment outcome to determine patient suitability for laryngectomy and neck dissection using eligibility criteria adopted by recent clinical trials. Treatment outcomes for surgery-eligible patients were compared to results of comparably staged patients in the surgical literature since 1980.
Results: Sixty-three patients (77%) were eligible for study. With a median follow-up of 3 years, radiotherapy controlled the primary in 8/20 evaluable glottic primaries and 21/41 evaluable supraglottic primaries. Forty-five percent of patients surviving 5 years retained a functional larynx. Sixteen of 29 relapsing patients were salvaged with surgery. Disease above the clavicles was controlled in 65% of T3T4N0N+ glottic primaries (compared to a published range of 53% to 79%) and 82% of T3N0 glottic primaries (compared to a published range of 69% to 84%). The 5-year overall survival of patients with T3T4 glottic cancer was 54% compared to a published range of 50% to 63%. The cause-specific survival (CSS) of patients with T3N0 glottic primaries (86% at 1 year and 73% at 2 years) was identical to the only published report of CSS in the surgical literature.
Conclusion: A policy of RRSS offers a good chance of laryngeal conservation without compromising ultimate locoregional control or survival when compared to primary laryngectomy and neck dissection in patients with locally advanced carcinoma of the larynx meeting the surgical eligibility of clinical trials.
Similar articles
-
The prognostic significance of tracheostomy in carcinoma of the larynx treated with radiotherapy and surgery for salvage.Int J Radiat Oncol Biol Phys. 1998 Apr 1;41(1):43-51. doi: 10.1016/s0360-3016(98)00030-3. Int J Radiat Oncol Biol Phys. 1998. PMID: 9588916
-
Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.Arch Otolaryngol Head Neck Surg. 2006 Jan;132(1):59-66. doi: 10.1001/archotol.132.1.59. Arch Otolaryngol Head Neck Surg. 2006. PMID: 16415431
-
Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone.Acta Otolaryngol. 2012 May;132(5):546-51. doi: 10.3109/00016489.2011.646008. Epub 2012 Jan 21. Acta Otolaryngol. 2012. PMID: 22264025
-
A critical review of radiotherapy in the management of T1 glottic carcinoma.Am J Otolaryngol. 1994 Jul-Aug;15(4):276-80. doi: 10.1016/0196-0709(94)90095-7. Am J Otolaryngol. 1994. PMID: 7978026 Review.
-
Radiotherapy for carcinoma of the supraglottis.Otolaryngol Clin North Am. 1997 Feb;30(1):145-61. Otolaryngol Clin North Am. 1997. PMID: 8995142 Review.
Cited by
-
Comparison of Treatment Outcomes for T3 Glottic Squamous Cell Carcinoma: A Meta-Analysis.Clin Exp Otorhinolaryngol. 2018 Mar;11(1):1-8. doi: 10.21053/ceo.2017.00717. Epub 2018 Feb 22. Clin Exp Otorhinolaryngol. 2018. PMID: 29486540 Free PMC article.
-
(125)I Seed Permanent Implantation as a Palliative Treatment for Stage III and IV Hypopharyngeal Carcinoma.Clin Exp Otorhinolaryngol. 2016 Sep;9(3):185-91. doi: 10.21053/ceo.2015.00213. Epub 2016 Jul 21. Clin Exp Otorhinolaryngol. 2016. PMID: 27440132 Free PMC article. Review.
-
Survival outcome depending on different treatment strategies in advanced stages III and IV laryngeal cancers: an audit of data from two European centres.Eur Arch Otorhinolaryngol. 2014 Mar;271(3):547-54. doi: 10.1007/s00405-013-2657-z. Epub 2013 Aug 31. Eur Arch Otorhinolaryngol. 2014. PMID: 23995705
-
Long-term results of intensity-modulated radiotherapy concomitant with chemotherapy for hypopharyngeal carcinoma aimed at laryngeal preservation.BMC Cancer. 2010 Mar 18;10:102. doi: 10.1186/1471-2407-10-102. BMC Cancer. 2010. PMID: 20298550 Free PMC article.
-
Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy.Radiat Oncol. 2011 May 24;6:54. doi: 10.1186/1748-717X-6-54. Radiat Oncol. 2011. PMID: 21609453 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials